Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Maureen P. Neary's publication output changed over time?
ScholarIQpublication output · 1996–2022
Output grew100% over the shown period — from 1 works in 1996 to 2 in 2022.
1
1
1
1
1
1
1
2
1
2
1996199920012003200720132014201620172022
What are the most-cited papers on Maureen P. Neary?
ScholarIQmost cited works
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
A. Simon Pickard, Maureen P. Neary, David Cella
Health and Quality of Life Outcomes. 2007938 CitationsOPEN ACCESS
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity
John G. McHutchison, John E. Ware, Martha Bayliss, Stephen Pianko, Janice K. Albrecht, Susannah Cort, Ilsoon Yang, Maureen P. Neary
Journal of Hepatology. 2001209 Citations
Incidence and prevalence of acromegaly in a large US health plan database
Tanya Burton, Elisabeth Le Nestour, Maureen P. Neary, W.H. Ludlam
S142774597. 2016122 CitationsOPEN ACCESS
Isotretinoin and antidepressant pharmacotherapy: A prescription sequence symmetry analysis
Kimberly Hersom, Maureen P. Neary, Hugh P. Levaux, Winslow Klaskala, John S. Strauss
S58727509. 200396 Citations
Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States
Michael S. Broder, Maureen P. Neary, Eunice Chang, Dasha Cherepanov, W.H. Ludlam
S142774597. 201491 Citations
Related on ScholarIQ
Johnson & Johnson (United States)
Institution
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Paper
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity
Paper
Incidence and prevalence of acromegaly in a large US health plan database
Paper
Isotretinoin and antidepressant pharmacotherapy: A prescription sequence symmetry analysis
Paper
Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States
Paper